IVF centre in Goa
Consultations in Panjim · Margao · Mapusa · Vasco
Call
Page 60 of 73Doctor path · Doctors' Textbook
Part B: IVF programme · Day OB-5
Page 60 of 73

OHSS: risk, prevention, recognition and management principles

On this page you will learn

Principles only. Medicines and doses are decided by the treating specialist for each patient; this page explains principles only.

Why OHSS matters in IVF

OHSS is the one serious complication that the IVF team itself creates. Stimulation grows many follicles; after the trigger, the corpora lutea release factors that make capillaries leak. Fluid shifts out of the blood into the abdomen and sometimes the chest. In its severe form a healthy young woman can need intensive care. Almost every severe case can be made less likely by decisions taken before and during stimulation, so prevention is the clinician's real work.

The 2024 ASRM guideline replaced its 2016 version and is built around prevention. The 2025 ESHRE stimulation update gives a similar ladder. Learn both side by side.

Source: 2024 (online Dec 2023), ASRM Practice Committee, Fertility and Sterility 121(2):230-245 - Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

Spotting the high-risk woman early

Risk is visible at the planning visit, long before the trigger. ASRM lists raised anti-Mullerian hormone (AMH), polycystic ovary syndrome (PCOS) and an expected high oocyte yield as the group to counsel. ESHRE asks for a written risk assessment for high response before stimulation, so that the protocol, the gonadotropin level, the trigger and the transfer plan are all chosen with that risk in mind.

Source: 2024 (online Dec 2023), ASRM Practice Committee, Fertility and Sterility 121(2):230-245 - Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

The prevention ladder

Think of prevention as steps on a ladder. Each step lowers risk; a high-risk woman usually needs several of them.

  1. Protocol. A GnRH antagonist protocol is preferred when OHSS is a concern, because it keeps the option of a GnRH agonist trigger (page 45).
  2. Gentler stimulation. ESHRE probably recommends a reduced gonadotropin starting level for predicted high responders. The exact choice belongs to the specialist.
  3. Agonist trigger. ASRM names the GnRH agonist trigger as the first-line trigger to cut moderate and severe OHSS. Its LH surge is short, so the ovaries are not driven for days as they are after human chorionic gonadotropin (hCG) (page 48).
  4. Freeze-all. Freezing every suitable embryo and transferring later removes the hCG of an early pregnancy from the picture. ESHRE recommends it to minimise late OHSS.
  5. Dopamine agonist. Both guidelines accept a dopamine agonist, started around the trigger, to lower the risk of early OHSS, mainly when hCG has been used. Here it is a concept only.

Source: 2024 (online Dec 2023), ASRM Practice Committee, Fertility and Sterility 121(2):230-245 - Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

Some popular steps have weak support. ASRM does not recommend coasting as a main strategy, a luteal GnRH antagonist alone, or letrozole to prevent OHSS. ESHRE prefers an agonist trigger to coasting.

Source: 2024 (online Dec 2023), ASRM Practice Committee, Fertility and Sterility 121(2):230-245 - Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline

Early and late OHSS

Early OHSS appears in the first days after the trigger and reflects the response to stimulation. Late OHSS starts later and is driven by the hCG of a new pregnancy, so it often lasts longer and can be more severe, especially with twins. This is why a high-risk woman who has had an hCG trigger is often advised not to have a fresh transfer.

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

Recognising it and when to admit

Mild OHSS gives bloating and discomfort and is common. Escalation shows as vomiting, a tightening abdomen, rapid weight gain, little urine, breathlessness, or pain in a leg or the chest. Any of these means review by the specialist the same day, never advice by phone alone.

The RCOG guideline sets admission criteria such as pain not settled by oral pain relief, persistent vomiting, falling urine output, tense ascites, breathlessness and laboratory signs of concentrated blood. The unit should keep these on one printed sheet.

Source: Feb 2016, Royal College of Obstetricians and Gynaecologists - Green-top Guideline No. 5: The management of ovarian hyperstimulation syndrome (third edition; a fourth edition is in development)

Management principles

Source: Feb 2016, Royal College of Obstetricians and Gynaecologists - Green-top Guideline No. 5: The management of ovarian hyperstimulation syndrome (third edition; a fourth edition is in development)

The patient education sheet

Every woman at risk goes home with a written sheet in plain language: what is normal, the warning signs, the clinic's round-the-clock number and what to do at night. Explain it in English, and in Hindi or Konkani where that helps, and record that it was given.

At the clinic

On Day OB-5 you follow a high-response patient's plan with the faculty: the risk assessment, the change of trigger or the decision to freeze all, and the words used with the couple. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).

The lab side

A freeze-all decision changes the embryologist's day: all suitable embryos go to the cryo-bank instead of the transfer catheter. The lab must hear the decision before the oocyte pick-up, so that consent, labels and storage are ready (page 54).

Common mistakes

Key points

Check yourself

Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.

1. Name four features that put a woman at high risk of OHSS before stimulation starts.

A high AMH or antral follicle count, polycystic ovaries or PCOS, a previous high response or OHSS, and young age.

2. Why does a GnRH agonist trigger lower the risk of early OHSS?

Its LH surge is short, so the corpora lutea get far less stimulus than after hCG, which acts for days.

3. What drives late OHSS, and what single step prevents it?

hCG from a new pregnancy; freezing all embryos and transferring later prevents it.

4. List five symptoms that mean same-day review by the specialist.

Vomiting, rapid weight gain or a growing abdomen, passing little urine, breathlessness, and leg or chest pain.

5. Why do women with severe OHSS need thromboprophylaxis?

Fluid leaves the vessels, the blood thickens and venous and arterial clots become more likely.

6. From page 34: why is OHSS after IUI rarer than after IVF?

IUI stimulation aims for one or two follicles, so far fewer corpora lutea form.

Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.

Contents and reading plan

Questions on this page

Can OHSS be prevented in IVF?

Risk can be lowered greatly with an antagonist protocol, an agonist trigger and freezing all embryos.

What is late OHSS?

OHSS that starts or worsens once a pregnancy begins, driven by the pregnancy's own hCG.

The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.